和元生物: 2025年第三次临时股东会会议资料

Core Viewpoint - The company is holding its third extraordinary general meeting of shareholders in 2025 to discuss and vote on the proposed 2025 Restricted Stock Incentive Plan and related management measures, aiming to enhance employee motivation and align interests among shareholders, the company, and core team members [7][8][11]. Group 1: Meeting Procedures - Shareholders and their representatives must sign in at least half an hour before the meeting and present necessary identification documents [2][3]. - The meeting will follow a specific agenda, allowing shareholders to exercise their rights to speak, inquire, and vote [2][3][5]. - Voting will be conducted through both on-site and online methods, with results announced after the meeting [4][5]. Group 2: Proposed Resolutions - The first resolution involves the approval of the 2025 Restricted Stock Incentive Plan draft, which aims to establish a long-term incentive mechanism to enhance employee engagement and align interests [7][8]. - The second resolution pertains to the management measures for implementing the 2025 Restricted Stock Incentive Plan, ensuring its effective execution [9][10]. - The third resolution seeks authorization for the board of directors to handle all matters related to the stock incentive plan, including adjustments and necessary approvals [10][11].